These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26862823)

  • 1. Efficacy of Psychoeducational Intervention on Allograft Function in Kidney Transplant Patients: 10-Year Results of a Prospective Randomized Study.
    Breu-Dejean N; Driot D; Dupouy J; Lapeyre-Mestre M; Rostaing L
    Exp Clin Transplant; 2016 Feb; 14(1):38-44. PubMed ID: 26862823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satisfaction and adherence with immunosuppressant treatment in renal transplant patients living with a working graft.
    Ortega F; Otero A; Crespo JF; Delgado JF; Borro JM; Cuervo J;
    J Nephrol; 2013; 26(2):297-305. PubMed ID: 22684646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predictive of medication nonadherence after renal transplantation: a French observational study.
    Couzi L; Moulin B; Morin MP; Albano L; Godin M; Barrou B; Alamartine E; Morelon E; Girardot-Seguin S; Mendes L; Misdrahi D; Cassuto E; Merville P
    Transplantation; 2013 Jan; 95(2):326-32. PubMed ID: 23149477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence in patients in the first year after kidney transplantation and its impact on graft loss and mortality: a cross-sectional and prospective study.
    Prihodova L; Nagyova I; Rosenberger J; Majernikova M; Roland R; Groothoff JW; van Dijk JP
    J Adv Nurs; 2014 Dec; 70(12):2871-83. PubMed ID: 24853863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study.
    Joost R; Dörje F; Schwitulla J; Eckardt KU; Hugo C
    Nephrol Dial Transplant; 2014 Aug; 29(8):1597-607. PubMed ID: 24914089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation.
    Massey EK; Tielen M; Laging M; Timman R; Beck DK; Khemai R; van Gelder T; Weimar W
    Transplantation; 2015 Feb; 99(2):375-80. PubMed ID: 25606787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the main determinants of kidney allograft long-term survival in the era of new immunosuppressive drugs.
    Hekmat R; Sturdevant M
    Saudi J Kidney Dis Transpl; 2019; 30(3):640-647. PubMed ID: 31249228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.
    O'Regan JA; Canney M; Connaughton DM; O'Kelly P; Williams Y; Collier G; deFreitas DG; O'Seaghdha CM; Conlon PJ
    J Nephrol; 2016 Apr; 29(2):269-276. PubMed ID: 26374111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different trends on the development and outcome of early kidney allograft dysfunction.
    Denisov VK; Zakharov VV; Onishchenko EV; Golubova TS; Mitsuk YG; Zakharova OV
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():228-30. PubMed ID: 25894160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help?
    Nerini E; Bruno F; Citterio F; Schena FP
    J Nephrol; 2016 Oct; 29(5):627-36. PubMed ID: 26885659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients.
    Hugon A; Roustit M; Lehmann A; Saint-Raymond C; Borrel E; Hilleret MN; Malvezzi P; Bedouch P; Pansu P; Allenet B
    Transplantation; 2014 Jul; 98(2):222-8. PubMed ID: 24926826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.
    Abdallah TB; Ounissi M; Cherif M; Helal I; Karoui C; Mhibik S; Bacha MM; Abderrahim E; Kheder A
    Exp Clin Transplant; 2010 Dec; 8(4):292-6. PubMed ID: 21143094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial.
    Garcia MF; Bravin AM; Garcia PD; Contti MM; Nga HS; Takase HM; de Andrade LG
    Int Urol Nephrol; 2015 Nov; 47(11):1899-905. PubMed ID: 26377496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating barriers to immunosuppressant medication adherence in renal transplant patients.
    Cossart AR; Staatz CE; Campbell SB; Isbel NM; Cottrell WN
    Nephrology (Carlton); 2019 Jan; 24(1):102-110. PubMed ID: 29278439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
    Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
    Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.